Cipla Q3 Results: Profit slumps 57% YoY to ₹676 crore — Here’s what hit the bottomline by Live mint | January 23, 2026 2:06 pm | Indian Stocks, Market, News Cipla Q3 Results: Pharma major Cipla posted a massive 57% YoY fall in net profit as production halt at Lanreotide manufacturing facility along with the one-time expense due to new labour codes, impacted the bottomline of the company.
